SOD1 and amyotrophic lateral sclerosis: Given (Lee et al., 2012) found reduced expression of MCT1 in the cortex of ALS patients and oligodendrocytes of SOD1 mutants it is tempting to speculate that enhancing oligodendrocyte provision of glycolysis products to axons could be neuroprotective in disease contexts.